We will have revenue then but you have to reserve bioreactors with a payment in order to get production started. With Samsung's increase in production capability there may be an immediate opening but that's not a given. If we can start a small production run after interim analysis with reservations for future production it will reduce the chance of a bottleneck in distribution. Which means increased sales, greater revenue and more lives saved.